Avid Bioservices's Return on Invested Capital Overview
Portfolio Pulse from Benzinga Insights
Avid Bioservices (NASDAQ:CDMO) reported Q4 sales of $39.80 million and a loss of $309 thousand. The company posted a Return on Invested Capital (ROIC) of 0.83%, indicating effective capital allocation. Avid Bioservices' Q4 earnings per share were $0.05, beating analyst predictions of $0.0.
June 22, 2023 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avid Bioservices reported better-than-expected Q4 earnings and a positive ROIC of 0.83%, indicating effective capital allocation.
Avid Bioservices reported better-than-expected Q4 earnings, which is a positive sign for investors. Additionally, the company's positive ROIC of 0.83% indicates that management is effectively allocating capital, which can lead to higher returns and earnings per share growth in the future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100